Inhibikase Therapeutics Inc
NASDAQ:IKT
Inhibikase Therapeutics Inc
NASDAQ:IKT
Price:
1.75
USD
-1.13%
Market Closed
Market Cap:
$231.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
S
|
Stericycle Inc
SWB:SY9
|
US |
|
C
|
Copenhagen Airports A/S
XBER:KLH
|
DK |
|
Shoprite Holdings Ltd
OTC:SRHGF
|
ZA |
|
J
|
Jaya Real Property Tbk PT
IDX:JRPT
|
ID |
|
S
|
Sandvik AB
OTC:SDVKY
|
SE |
|
Zepp Health Corp
NYSE:ZEPP
|
CN |
|
S
|
Secure Energy Services Inc
F:SEP
|
CA |
|
Gold Fields Ltd
F:EDGA
|
ZA |
|
S
|
Swire Pacific Ltd
XMUN:SWI
|
HK |
|
C
|
Cadiz Inc
F:2ZC
|
US |
|
I
|
IQVIA Holdings Inc
XBER:QTS
|
US |
|
C
|
China Environmental Resources Group Ltd
HKEX:1130
|
HK |
|
3
|
3M Co
DUS:MMM
|
US |
|
N
|
Netflix Inc
MIL:NFLX
|
US |
Multiples-Based Value
The Multiples-Based Value for Inhibikase Therapeutics Inc (IKT) under the Base Case is hidden
USD.
Compared with the current market price of 1.75 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IKT Multiples-Based Value
LOCKED
